Additionally, semaglutide GLP-1 injections, when given under medical supervision, can also help to reduce appetite, leading to weight loss
Participants with obesity (body mass index (BMI) 30 kg/m) and moderate-to-severe KOA pain experienced significantly greater reductions in body weight and OA-related pain with weekly semaglutide injections compared to placebo [52]
Members get a telehealth evaluation with a licensed clinician, ongoing support, and direct-to-door delivery of medication, so the entire process stays under one roof
While gradual dose titration is common, using GLP-1s at micro-doses specifically for menopause is currently unapproved and the long-term risks are unknown
Microdosing GLP-1s is hardly a one-size fits all process, and its important to use a telehealth platform that offers a truly personalized plan